Free TX MPJE Exam Flashcards

The Texas State Board of Pharmacy (TSBP) is Texas's independent state regulatory agency that licenses pharmacists and pharmacies and enforces the Texas Pharmacy Act; NABP develops and administers the multistate MPJE exam itself, but Texas law and rules are enforced solely by TSBP.

Texas pharmacist licenses renew biennially (every 2 years), with expiration tied to the license holder's birth month.

Texas requires 30 hours of CE per 2-year renewal period, of which at least 1 hour must cover Texas pharmacy law.

Texas requires 1,500 internship hours before licensure; day-to-day regulatory compliance at a pharmacy rests with the pharmacist-in-charge (PIC).

1:6 — one pharmacist may supervise up to 6 technicians/technician-trainees on-site.

At most 3 of the 6 may be pharmacy technician trainees; trainee status is time-limited, and the individual must complete registration and certification requirements to continue working as a technician.

Yes — technicians must hold active TSBP registration and work only under direct pharmacist supervision; unregistered individuals may not perform technician duties.

No — verification of accuracy and patient counseling are pharmacist-only tasks; technicians may perform mechanical/technical functions but cannot exercise professional judgment.

DEA registration renews every 3 years, while the TSBP pharmacist license and pharmacy permit renew every 2 years — the two renewal clocks run independently.

The first letter is a registrant-type code (for example A, B, or F for practitioners, M for mid-level practitioners); the second letter is the first letter of the registrant's last name; the 7 digits are a numeric identifier that includes a built-in check-digit formula.

Yes — mid-level practitioners with Texas prescriptive authority obtain their own DEA registration (an M-prefix number) and may prescribe controlled substances within their delegated scope of practice.

High abuse potential with no FDA-accepted medical use in the U.S. and no accepted safety for use even under medical supervision — Schedule I drugs cannot be legally prescribed.

Zero — Schedule II prescriptions can never be refilled; each fill requires a brand-new prescription (written or electronic).

Up to 5 refills within 6 months of the original issue date; after that limit, a new prescription is required.

No more than 200 mg of codeine per 100 mL (or per 100 g for solid forms) — above that threshold the product is scheduled more restrictively.

Only in a bona fide emergency; the prescriber must follow up with a signed written or electronic prescription within 7 days of the oral order.

Buprenorphine is Schedule III, so it follows the Schedule III-V refill rule (up to 5 refills in 6 months) rather than the no-refill Schedule II rule, even though it treats opioid dependence.

Patient name, drug name and strength, prescriber's name and DEA number, date of issue, and prescriber's signature — missing any required element makes the prescription invalid to fill.

It blocks the pharmacist from substituting a generic equivalent, requiring the brand-name product be dispensed even when a bioequivalent generic exists.

The pharmacist shares legal responsibility with the prescriber to ensure a controlled-substance prescription was issued for a legitimate medical purpose in the usual course of professional practice — a pharmacist can be held liable for knowingly filling an invalid prescription.

72 hours from the initial partial fill; if the remaining quantity isn't dispensed within that window, a new prescription is required to complete it.

By issuing multiple separate prescriptions (totaling up to a 90-day supply) with instructions or earliest-fill dates on each, rather than one prescription with refills, since Schedule II never permits refills.

30 days from the date of issuance (22 TAC 315.3, effective 2021, replacing the old 21-day rule); after 30 days it can no longer be dispensed and a new prescription is required.

OBRA-90 (Omnibus Budget Reconciliation Act of 1990) — it requires pharmacists to offer counseling on new prescriptions and perform prospective DUR before dispensing.

Drug interactions, therapeutic duplication, incorrect dosage or duration, and drug-allergy contraindications.

The pharmacist must offer counseling on every new prescription; the patient may decline the offer, but making the offer itself is mandatory.

Under age 14 — Texas pharmacists generally must refer younger children to another qualified provider for immunizations.

Yes — influenza vaccine has a lower age exception, permitting pharmacist administration to patients age 7 and older.

Since March 2020 — Texas made PMP (PMP Aware) queries mandatory before prescribing or dispensing specific trigger-drug prescriptions.

Opioids, benzodiazepines, barbiturates, and carisoprodol — prescribing or dispensing any of these requires a PMP query.

Before prescribing or dispensing the trigger-drug prescription, not afterward.

Veterinarians — they are exempt from the mandatory PMP query requirement that applies to human prescribers and dispensers of trigger drugs.

No — Schedule II prescriptions are never transferable between pharmacies under any circumstance.

One time only, unless the pharmacies share a real-time online database, in which case multiple transfers are allowed.

The pharmacist should substitute the equivalent generic by default unless the prescriber has written 'Dispense as Written' (DAW) or the required brand-medically-necessary language.

It confirms the generic is therapeutically and bioequivalent to the reference brand, meaning it is substitutable without prescriber approval, absent a DAW restriction.

Pharmacy name and address, prescription number, patient name, drug name and strength, directions for use, and prescriber name — omitting a required element can make the product misbranded.

No — WAC/wholesale cost information is not a required dispensing-label element.

It's exempt from PPPA (Poison Prevention Packaging Act) child-resistant packaging, because a resistant cap could delay a cardiac patient's emergency access to the dose.

3.6 grams per day and 9 grams per 30-day period for an individual purchaser.

DEA Form 222 (or its electronic CSOS equivalent) — used for Schedule II distribution/ordering, not for Schedule III-V.

DEA Form 106 — filed with DEA (and typically local police) when controlled substances are stolen or significantly unaccounted for.

2 years — Texas's retention requirement matches the federal minimum of 2 years.

Annually — on May 1 or the pharmacy's regular general physical inventory date (22 TAC 291.17), stricter than the federal biennial minimum; Schedule II drugs must always be counted exactly, never estimated.

When the container holds more than 1,000 dosage units — above that threshold, an exact count is required instead of an estimate.

USP <795> covers nonsterile compounding preparations; USP <797> covers sterile compounding preparations.

USP <800> — sets standards for handling hazardous drugs to protect personnel and the environment during compounding and handling.

Category 1 has a shorter beyond-use date (about 12 hours at room temperature or 24 hours refrigerated) and less testing; Category 2 allows a longer beyond-use date but requires additional environmental monitoring and testing.

Class A is a community pharmacy that dispenses to the public; Class C is an institutional pharmacy serving inpatients in a hospital or similar facility.

Biennially (every 2 years) — the renewal cycle applies uniformly across all Texas pharmacy license classes, A through E.